A REPORT FROM THE AMERICAN COLLEGE OF RHEUMATOLOGY/ASSOCIATION OF RHEUMATOLOGY HEALTH PROFESSIONALS (ACR/ARHP)-2012 ANNUAL MEETING (NOVEMBER 9-14, 2012-WASHINGTON, DC, USA)

被引:0
|
作者
Croasdell, G. [1 ]
机构
[1] Thomson Reuters, London, England
关键词
Rheumatology; JAK3; inhibitors; BTK inhibitors; Anti-IL-21 monoclonal antibody; IRAK-4; Type I interferon receptor monoclonal antibody; BET inhibitors;
D O I
10.1358/dot.2013.49.2.1937427
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The annual meeting of the American College of Rheumatology (ACR), jointly held with the Association of Rheumatology Health Professionals (ARNP), brought together attendees focused on all aspects of rheumatology, including researchers looking into treatment options and various services around the care of rheumatologic conditions. As well as networking opportunities at the meeting, there were a wide range of symposia and posters available covering various conditions and levels of research. There were also educational and meet-the-professor sessions. This report will cover a selection of interesting talks from poster and oral sessions on the latest preclinical and clinical research.
引用
收藏
页码:153 / 155
页数:3
相关论文
共 15 条